Evidence map›Paper›PMID 31700821›Full record

ArticleIranian journal of public health2019

The Expression Level of

Yu Huang, Min Luo, Junqing Huang, Shaoxin Huang, Liuxia Wei, Yumei Zhang, Zhiming Zhang

Abstract read
PubMed Full text at PMC
In one paragraph

Article in Iranian journal of public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yu HuangDepartment of Medical Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, P.R. China.
Min LuoDepartment of Medical Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, P.R. China.
Junqing HuangDepartment of Medical Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, P.R. China.
Shaoxin HuangDepartment of Medical Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, P.R. China.
Liuxia WeiDepartment of Medical Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, P.R. China.
Yumei ZhangDepartment of Medical Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, P.R. China.
Zhiming ZhangDepartment of Medical Oncology, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe aimed to investigate the expression level of breast cancer susceptibility gene 2 (

methodsOverall, 102 patients treated in Affiliated Tumor Hospital of Guangxi Medical University, China from April 2013 to August 2017 were enrolled as experimental group, including 58 patients with noninvasive MC (group A) and 44 with invasive MC (group B). Fifty healthy volunteers at the same time were enrolled as control group. The relative expression of

resultsIn the experimental group, the expression level of

conclusion

Indexed as

BRCA2ChemotherapyInvasive mammary cancerNoninvasive mammary cancer

Identifiers

PMID31700821
PMCPMC6825661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.